Clinical Trial Update: Doxycycline and TUDCA in Patients With Transthyretin Amyloid Cardiomyopathy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial investigating doxycycline and TUDCA in transthyretin amyloid cardiomyopathy has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyloidosis
• Senile Cardiac Amyloidosis
• Transthyretin Amyloid Cardiomyopathy

Drugs mentioned

• Doxycycline (Doxycycline)
• TUDCA (Tauroursodeoxycholic acid)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Amyloidosis; Heart (Manifestation), Senile Cardiac Amyloidosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-12-04